Literature DB >> 10458270

The effect of monomer-to-powder ratio on the material properties of cranioplastic.

L E Jasper1, H Deramond, J M Mathis, S M Belkoff.   

Abstract

Percutaneous vertebroplasty consists of injecting polymethylmethacrylate cement into the cancellous bone of vertebral bodies for the treatment of various lesions of the spine, including osteoporotic compression fractures. Clinicians practicing vertebroplasty commonly alter the mixture of monomer-to-powder recommended by the manufacturer in an effort to decrease viscosity and increase the working time. The purpose of the current study was to measure the effect that varying the monomer-to-powder ratio has on the compressive material properties of a cement (Cranioplastic) commonly used in vertebroplasty. Cylindrical specimens were prepared varying a monomer-to-polymer ratio of 0.40 to 1.07 ml/g and tested per the American Society for Testing and Materials standard F451. Specimens prepared at 0.53 mL/g, which is near the manufacturer's recommended monomer-to-polymer mixture of 0.57 mL/g, exhibited the greatest mean values for ultimate compressive stress, yield stress, and elastic modulus. Specimens prepared at higher or lower ratios exhibited diminished strength, in some cases by as much as 24%. Although altering the monomer-to-powder ratio affects the cement's material properties, it is as yet unknown if the decrease is clinically significant.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10458270     DOI: 10.1016/s8756-3282(99)00129-5

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  9 in total

Review 1.  Percutaneous vertebroplasty: a developing standard of care for vertebral compression fractures.

Authors:  J M Mathis; J D Barr; S M Belkoff; M S Barr; M E Jensen; H Deramond
Journal:  AJNR Am J Neuroradiol       Date:  2001-02       Impact factor: 3.825

2.  Ex vivo biomechanical comparison of hydroxyapatite and polymethylmethacrylate cements for use with vertebroplasty.

Authors:  Stephen M Belkoff; John M Mathis; Louis E Jasper
Journal:  AJNR Am J Neuroradiol       Date:  2002 Nov-Dec       Impact factor: 3.825

Review 3.  Vertebroplasty versus kyphoplasty: a comparison and contrast.

Authors:  John M Mathis; A Orlando Ortiz; Gregg H Zoarski
Journal:  AJNR Am J Neuroradiol       Date:  2004-05       Impact factor: 3.825

4.  Bone cements: review of their physiochemical and biochemical properties in percutaneous vertebroplasty.

Authors:  Matthew J Provenzano; Kieran P J Murphy; Lee H Riley
Journal:  AJNR Am J Neuroradiol       Date:  2004-08       Impact factor: 3.825

5.  Material properties of various cements for use with vertebroplasty.

Authors:  L E Jasper; H Deramond; J M Mathis; S M Belkoff
Journal:  J Mater Sci Mater Med       Date:  2002-01       Impact factor: 3.896

6.  An ex vivo biomechanical evaluation of a hydroxyapatite cement for use with kyphoplasty.

Authors:  S M Belkoff; J M Mathis; H Deramond; L E Jasper
Journal:  AJNR Am J Neuroradiol       Date:  2001 Jun-Jul       Impact factor: 3.825

7.  Clinical results of an open prospective study of a bis-GMA composite in percutaneous vertebral augmentation.

Authors:  Jean Palussière; Jérôme Berge; Afshin Gangi; Anne Cotten; Anne Pasco; Rudolf Bertagnoli; Hans Jaksche; Paolo Carpeggiani; Hervé Deramond
Journal:  Eur Spine J       Date:  2005-06-02       Impact factor: 3.134

8.  Extending polymerization time of polymethylmethacrylate cement in percutaneous vertebroplasty with ice bath cooling.

Authors:  Ram Chavali; Rick Resijek; Steven K Knight; In Sup Choi
Journal:  AJNR Am J Neuroradiol       Date:  2003-03       Impact factor: 3.825

9.  Percutaneous vertebroplasty with high- versus low-viscosity bone cement for osteoporotic vertebral compression fractures.

Authors:  Feng Miao; Xiaojun Zeng; Wei Wang; Zhou Zhao
Journal:  J Orthop Surg Res       Date:  2020-08-06       Impact factor: 2.359

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.